Free Trial

Pathway Financial Advisers LLC Raises Stock Position in Xylem Inc. (NYSE:XYL)

Xylem logo with Business Services background

Key Points

  • Pathway Financial Advisers LLC significantly increased its stake in Xylem Inc. by 1,690.6%, holding 5,694 shares valued at approximately $680,000 after purchasing 5,376 additional shares in the first quarter.
  • Xylem reported earnings per share of $1.26 for the last quarter, surpassing analysts' expectations, and noted a 6.1% increase in revenue compared to the previous year.
  • The company recently announced a quarterly dividend of $0.40, translating to an annualized dividend yield of 1.1%, with a payout ratio of 43.01%.
  • MarketBeat previews top five stocks to own in September.

Pathway Financial Advisers LLC grew its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 1,690.6% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 5,694 shares of the industrial products company's stock after acquiring an additional 5,376 shares during the quarter. Pathway Financial Advisers LLC's holdings in Xylem were worth $680,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of XYL. Dempze Nancy E raised its position in Xylem by 0.3% in the fourth quarter. Dempze Nancy E now owns 25,761 shares of the industrial products company's stock valued at $2,989,000 after purchasing an additional 88 shares during the last quarter. Townsquare Capital LLC increased its stake in shares of Xylem by 0.8% in the fourth quarter. Townsquare Capital LLC now owns 11,074 shares of the industrial products company's stock valued at $1,285,000 after buying an additional 88 shares during the period. Center for Financial Planning Inc. boosted its position in shares of Xylem by 52.0% during the 1st quarter. Center for Financial Planning Inc. now owns 266 shares of the industrial products company's stock valued at $32,000 after purchasing an additional 91 shares in the last quarter. Keel Point LLC boosted its holdings in Xylem by 4.1% in the fourth quarter. Keel Point LLC now owns 2,371 shares of the industrial products company's stock worth $275,000 after acquiring an additional 93 shares in the last quarter. Finally, SageView Advisory Group LLC boosted its holdings in Xylem by 3.6% in the fourth quarter. SageView Advisory Group LLC now owns 2,790 shares of the industrial products company's stock worth $324,000 after acquiring an additional 98 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of analysts recently commented on the company. Royal Bank Of Canada increased their price target on Xylem from $143.00 to $147.00 and gave the company an "outperform" rating in a research report on Wednesday, April 30th. Stifel Nicolaus raised their target price on Xylem from $162.00 to $175.00 and gave the stock a "buy" rating in a research report on Friday. Raymond James Financial raised Xylem to a "hold" rating in a report on Thursday, May 15th. Robert W. Baird cut their price target on Xylem from $149.00 to $146.00 and set an "outperform" rating for the company in a report on Wednesday, April 30th. Finally, Citigroup reaffirmed a "buy" rating and issued a $152.00 price target (up from $137.00) on shares of Xylem in a report on Monday, July 14th. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, Xylem presently has an average rating of "Moderate Buy" and a consensus price target of $151.14.

View Our Latest Research Report on XYL

Xylem Stock Performance

Shares of NYSE:XYL traded up $1.71 during midday trading on Monday, hitting $143.89. The company had a trading volume of 1,593,476 shares, compared to its average volume of 1,132,611. The company has a market cap of $35.02 billion, a price-to-earnings ratio of 37.37, a PEG ratio of 2.51 and a beta of 1.11. The company has a fifty day moving average of $129.44 and a two-hundred day moving average of $124.38. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.90 and a quick ratio of 1.43. Xylem Inc. has a 12-month low of $100.47 and a 12-month high of $144.83.

Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 EPS for the quarter, beating analysts' consensus estimates of $1.15 by $0.11. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The firm had revenue of $2.30 billion during the quarter, compared to the consensus estimate of $2.20 billion. During the same quarter last year, the firm earned $1.09 EPS. The firm's revenue for the quarter was up 6.1% compared to the same quarter last year. On average, equities research analysts expect that Xylem Inc. will post 4.65 EPS for the current fiscal year.

Xylem Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, June 26th. Stockholders of record on Thursday, May 29th were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Thursday, May 29th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. Xylem's dividend payout ratio (DPR) is 41.56%.

Xylem Company Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Further Reading

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines